What have we learnt thus far from mice with disrupted P-glycoprotein genes?

This publication has 32 references indexed in Scilit:

• PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
  Annual Review of Biochemistry, 1996
• Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.
  Journal of Clinical Investigation, 1995
• Characterization of Prenylcysteines That Interact with P-glycoprotein and Inhibit Drug Transport in Tumor Cells
  Journal of Biological Chemistry, 1995
• Multidrug resistance and the role of P-glycoprotein knockout mice
  European Journal of Cancer, 1995
• Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
  Cell, 1994
• P-glycoprotein expression and function in circulating blood cells from normal volunteers
  Blood, 1994
• Clinical relevance of P-glycoprotein expression in haematological malignancies
  Leukemia Research, 1994
• Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells
  Cancer Immunology, Immunotherapy, 1993
• Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals
  Pharmacology & Therapeutics, 1993
• Multidrug resistance activity in human lymphocytes
  Human Immunology, 1991